Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

This bill requires all health insurance plans in New Jersey - including hospital service contracts, medical service contracts, individual/group health insurance, health maintenance organizations, and state-run programs - to cover the cost of continuous glucose monitoring systems prescribed for treating glycogen storage disease. It directly affects patients with glycogen storage disease who need this monitoring technology and the insurance providers that must cover it. The law mandates coverage "to the same extent as for any other medical condition," meaning insurers cannot impose additional restrictions or higher out-of-pocket costs for this treatment. The requirement applies to all relevant insurance plans delivered, issued, or renewed in New Jersey after the bill's effective date.